CAS NO: | 161796-78-7 |
包装 | 价格(元) |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
1 g | 电议 |
生物活性 | Esomeprazole sodium ((S)-Omeprazole sodium) is a potent and orally activeproton pumpinhibitor. Esomeprazole reduces acid secretion through inhibition of theH+, K+-ATPasein gastric parietal cells. Esomeprazole acts as an exosome inhibitor by blocking the exosome release via the inhibition of V-H+-ATPases[4]. Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research[1][2][3]. | ||||||||||||||||
IC50& Target | H+, K+-ATPase[1][2] | ||||||||||||||||
体外研究 (In Vitro) | Esomeprazole (25-100 μM; 20 hours; MDA-MB-468 cells) treatment suppresses growth of triple-negative breast cancer cell in vitro in a dose-dependent manner through increase in their intracellular acidification[1]. Cell Viability Assay[1]
| ||||||||||||||||
体内研究 (In Vivo) | Esomeprazole (30-300 mg/kg; oral gavage; daily; for 19 or 11 days; C57BL/6J mice) treatment significantly inhibits the progression of fibrosis throughout the lungs of the animals. Esomeprazole also reduces circulating markers of inflammation and fibrosis[2].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 367.40 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C17H18N3NaO3S | ||||||||||||||||
CAS 号 | 161796-78-7 | ||||||||||||||||
中文名称 | 埃索美拉唑钠盐 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture and light *该产品在溶液状态不稳定,建议您现用现配,即刻使用。 | ||||||||||||||||
溶解性数据 | In Vitro: H2O : 100 mg/mL(272.18 mM;Need ultrasonic) DMSO : 100 mg/mL(272.18 mM;Need ultrasonic) Ethanol : 50 mg/mL(136.09 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液;该产品在溶液状态不稳定,建议您现用现配,即刻使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|